Table 5.
Treatmentsa | P-value | |||||||
---|---|---|---|---|---|---|---|---|
Day 4 PI | CN | CP | NN | NP | RSDb | Challenge | Probiotic | Interaction |
TRIAL 1: Salmonella | ||||||||
Villus height (μm) | 186 | 141 | 250 | 296 | 46.9 | <0.001 | 0.992 | 0.361 |
Crypt depth (μm) | 244 | 245 | 206 | 218 | 24.5 | 0.007 | 0.562 | 0.581 |
Ratio Villus:Crypt | 0.78 | 0.58 | 1.22 | 1.37 | 0.242 | <0.001 | 0.818 | 0.107 |
IELc (N° cel/100 μm) | 2.09 | 2.03 | 0.75 | 1.44 | 1.027 | 0.042 | 0.482 | 0.407 |
TRIAL 2: ETEC K88 | ||||||||
Villus height (μm) | 224 | 223 | 252 | 260 | 49.7 | 0.152 | 0.886 | 0.818 |
Crypt depth (μm) | 205 | 213 | 187 | 207 | 20.7 | 0.194 | 0.144 | 0.504 |
Ratio Villus:Crypt | 1.11 | 1.05 | 1.34 | 1.25 | 0.258 | 0.066 | 0.524 | 0.877 |
IELc (N° cel/100 μm) | 2.64 | 2.74 | 1.79 | 2.36 | 0.420 | 0.004 | 0.091 | 0.224 |
Treatments: CN, challenged + no probiotic; CP, challenged + probiotic; NN, no challenge + no probiotic; NP, no challenge + probiotic.
Residual standard deviation. n = 8 for groups CN and CP, n = 4 for groups NN and NP.
IEL = Villus intraepithelial lymphocytes.